代谢健康型肥胖成人的心肌组织水平特征
本研究为前瞻性三中心心脏磁共振研究,纳入120名无心脏症状的肥胖非糖尿病个体,发现代谢健康型肥胖(MHO)者已有心肌纤维化和水肿指标升高及亚临床收缩舒张功能减退,且代谢不健康型肥胖(MUHO)纤维化更重。
要点
- MHO成人CMR示ECV和native T2升高,提示亚临床心肌纤维化与水肿。
- MHO者左室射血分数正常但整体纵向应变及早期舒张应变率减低。
- BMI增高是心肌纤维化的独立危险因素(OR 6.28)。
核心结论
- 无论代谢是否健康,肥胖成人均存在亚临床心肌组织水平重构,早期识别心脏损害有助于预防心衰。
研究设计与样本
- 前瞻性、三中心注册研究(EARLY-MYO-OBESITY,NCT05277779),纳入无心脏症状的肥胖非糖尿病个体,行心脏磁共振检查。
- 共120例:MHO 32例(平均38岁,41%男性)、代谢健康非肥胖对照32例(平均37岁,41%男性)、MUHO 56例(平均37岁,55%男性)。
- 测量细胞外容积分数(ECV)和native T2值作为心肌纤维化和水肿指标,组织追踪分析整体纵向峰值收缩应变和早期舒张纵向应变率。
关键影像表现/征象
- MHO组ECV和native T2值均高于健康对照组(均P<0.001)。
- MUHO组ECV高于MHO组(P=0.002)。
- MHO组心肌纤维化患病率为44%(14/32),MUHO组为71%(40/56)。
- 各组左室射血分数无组间差异,但MHO组整体纵向峰值收缩应变和早期舒张纵向应变率减低,提示亚临床收缩和舒张功能障碍。
诊断标准与关键数值
- 心肌纤维化以ECV升高为指标,MHO组患病率44%(14/32),MUHO组71%(40/56)。
- 多因素回归显示BMI增高是心肌纤维化的独立危险因素(OR 6.28,95%CI 3.17-12.47,P<0.001)。
临床应用与阅片要点
- 对肥胖患者行CMR时,除常规功能指标外应关注ECV、native T2及应变参数,以识别亚临床心肌损害。
- MHO并非良性状态,阅片报告可提示心肌纤维化可能,建议结合代谢状态综合评估。
局限性
- 样本量较小(MHO仅32例),为三中心前瞻性研究,结论需更大样本验证。
- 原文未报告随访数据,无法确定亚临床改变与临床心衰的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: It remains unclear whether adults with metabolically healthy obesity (MHO) have altered myocardial tissue-level characteristics.
OBJECTIVES: This study aims to assess the subclinical myocardial tissue-level characteristics of adults with MHO.
METHODS: The EARLY-MYO-OBESITY (EARLY Assessment of MYOcardial Tissue Characteristics in OBESITY; NCT05277779) registry was a prospective, 3-center, cardiac imaging study of obese nondiabetic individuals without cardiac symptoms who underwent cardiac magnetic resonance. Myocardial tissue-level characteristics, including extracellular volume fraction (ECV) and native T2 values, were measured as indicators of myocardial fibrosis and edema. Global longitudinal peak systolic strain and early diastolic longitudinal strain rate were assessed by tissue tracking analysis to detect subclinical systolic and diastolic dysfunction.
RESULTS: A total of 120 participants were included: MHO (n = 32; mean age, 38 years; 41% men), metabolically healthy controls without obesity (n = 32; mean age: 37 years; 41% men), and metabolically unhealthy obesity (MUHO) (n = 56; mean age: 37 years; 55% men). The MHO group had higher ECV and native T2 values than healthy controls (both P < 0.001); furthermore, the ECV was higher in the MUHO group than in the MHO group (P = 0.002). The prevalence of myocardial fibrosis was 44% (14 of 32) in the MHO group and 71% (40 of 56) in the MUHO group. Although there was no intergroup difference in left ventricular ejection fraction, the MHO group had reduced global longitudinal peak systolic and early diastolic longitudinal strain rates, indicating subclinical systolic and diastolic dysfunction. Multivariate regression analysis identified increased body mass index to be an independent risk factor for myocardial fibrosis (OR: 6.28 [95% CI: 3.17-12.47]; P < 0.001).
CONCLUSIONS: This study provides the first evidence of subclinical myocardial tissue-level remodeling in adults with obesity, regardless of metabolic health. Early identification of cardiac impairment may facilitate preventive strategies against heart failure in the MHO population. (EARLY Assessment of MYOcardial Tissue Characteristics in OBESITY [EARLY-MYO-OBESITY]; NCT05277779).
引用
- Zhao, Huang, Jiang, et al. Myocardial Tissue-Level Characteristics of Adults With Metabolically Healthy Obesity. JACC Cardiovasc Imaging. 2023. PMID: 37052557. doi:10.1016/j.jcmg.2023.01.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。